Agilent Technologies Down Almost 30% In 2022, Is Now Time To Buy?

NYSE: A | Agilent Technologies Inc. News, Ratings, and Charts

A – Shares of the medical diagnostics and research company Agilent Technologies (A) have plunged nearly 30% year-to-date. However, Wall Street analysts see significant upside potential in the stock, given its solid fundamentals. So, is the stock a buy now? Read on to find out.

Application-focused solutions provider Agilent Technologies, Inc. (A) operates in Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab segments. The company offers its services to the life sciences, diagnostics, and applied chemical markets.

Earlier this month, A announced its agreement with Amazon Web Services and NVIDIA Corporation’s (NVDA) technologies to showcase time and cost-efficient genomic discoveries for advanced treatment development using secure cloud technology. This collaboration should prove strategically beneficial for the company.

Also, A launched its new LC/MS and GC/MS quadrupole mass spectrometers, advanced devices built to simplify lab researchers’ operating processes.

Despite its recent developments, A has lost 8.4% over the past month to close Friday’s trading session at $112.71. Moreover, it has lost 29.4% year-to-date. However, Wall Street analysts expect the stock to hit $148.60 in the near term, indicating a potential upside of 31.8%.

Here is what could shape A’s performance in the near term:

Strong Financials

For the second quarter ended April 30, 2022, A’s net revenue came in at $1.61 billion, up 5.4% year-over-year. Its non-GAAP net income came in at $340 million, up 13.7% year-over-year. Moreover, its non-GAAP EPS came in at $1.13, up 16.5% year-over-year. In addition, its income from operations came in at $360 million, up 25% year-over-year.

Solid Profit Margins

A’s trailing-twelve-month EBIT margin of 23.20% is significantly higher than the industry average of 1.27%, while its trailing-twelve-month EBITDA margin of 28.28% is 617.2% higher than the industry average of 3.94%.

Moreover, its trailing- twelve-month net income margin of 19.35% compare with the industry average of negative 1.93%. Also, its trailing-twelve-month asset turnover ratio of 0.63% is 77.2% higher than the industry average of 0.35%.

Favorable Analyst Expectations

Analysts expect A’s revenue to increase 15.2% year-over-year to $6.42 billion in 2022 and 7.3% year-over-year to $6.88 billion in 2023. Also, its EPS is expected to grow 22.5% in the current year and 10.4% next year.

Moreover, its EPS is estimated to increase 14.4% per annum for the next five years. The stock surpassed EPS estimates in three of the four trailing quarters.

Among the ten Wall Street analysts that rated A, seven rated it Buy, while three rated it Hold.

POWR Ratings Reflect Promising Outlook

The stock has an overall rating of A, equating to Strong Buy in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

It has a B grade for Quality, consistent with its higher-than-industry profit margins.

The stock has a C grade for Stability, in sync with its beta of 1.06.

In the 53-stock Medical – Diagnostics/Research industry, A is ranked #3.

Click here for the additional POWR Ratings for A (Growth, Value, Momentum, and Sentiment).

View all the top stocks in the Medical – Diagnostics/Research industry here.

Bottom Line

The company has delivered significant growth in its last reported quarter. Moreover, its revenue and EPS have increased at CAGRs of 9.2% and 6.4% over the past three years, respectively. So, given A’s impressive profit margins and upside potential, I think investors should take advantage of the dip and scoop up its shares.

How Does Agilent Technologies (A) Stack Up Against its Peers?

While A has an overall POWR Rating of A, one might consider looking at its industry peer Qiagen N.V. (QGEN), which has an overall A (Strong Buy) rating, and Waters Corporation (WAT), which has an overall B (Buy) rating.


A shares were trading at $112.71 per share on Monday afternoon, down $2.25 (-1.96%). Year-to-date, A has declined -29.20%, versus a -22.73% rise in the benchmark S&P 500 index during the same period.


About the Author: Riddhima Chakraborty


Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
AGet RatingGet RatingGet Rating
QGENGet RatingGet RatingGet Rating
WATGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Will Stocks Continue to Rise...Or Time for Rug Pull?

It’s hard not to celebrate each new high for the S&P 500 (SPY). Yet with high inflation not dead and buried then perhaps this stock market celebration is a tad early. That is why you need to hear what 44 year investment veteran Steve Reitmeister is saying about what comes next for the stock market and how to stay on the right side of the action. Read on below for more...

4 Software Stocks Primed for Major Upside in 2024

The software industry is thriving, buoyed by digital transformation, soaring demand for cloud solutions, and the integration of advanced technologies like AI and ML, presenting lucrative opportunities for savvy investors. So, let’s look at tech stocks SS&C Technologies (SSNC), Informatica (INFA), Verint Systems (VRNT), and Yext (YEXT) poised for significant upside in 2024. Read on…

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more…

3 Bargain Internet Stock Buys for Savvy Investors

The increased internet penetration is reshaping various industries, driving digital transformation, connectivity, and access to services like e-commerce, remote work, and online entertainment. Thus, robust internet stocks Jamf Holding (JAMF), Upwork (UPWK), and TrueCar (TRUE), which are trading at discounts to their peers, could be ideal buys. Keep reading…

2 Paths for Stocks from Here

The recent rally for the S&P 500 (SPY) is nice to see. However, it is quite possible this is the end of the line for recent stock gains with more downside ahead. To explain the 2 distinct possibilities for stocks at this time is 44 year investment veteran Steve Reitmeister who shares this updated marketing outlook with trading plan and top picks in the article below...

Read More Stories

More Agilent Technologies Inc. (A) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All A News